Effects of Capros in Patients With Type-1 Diabetes
Public ClinicalTrials.gov record NCT02634216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Study identification
- NCT ID
- NCT02634216
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Ohio State University
- Other
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- Capros Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 10 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2014
- Primary completion
- May 24, 2016
- Completion
- May 24, 2016
- Last update posted
- Nov 19, 2019
2015 – 2016
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Carepoint East 543 Taylor Ave. | Columbus | Ohio | 43203 | — |
| Martha Morehouse Medical Plaza 2050 Kenny Road | Columbus | Ohio | 43210 | — |
| Davis Heart and Lung Research Institute | Columbus | Ohio | 43212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02634216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2019 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02634216 live on ClinicalTrials.gov.